To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer likely to remove lid on drug price increases in January

Chairman and CEO Ian Read said Pfizer Inc. (NYSE:PFE) will likely end its agreement to defer drug price increases and return to "business as normal" by year end. Read's comments, which came during the pharma’s 3Q18 earnings conference call Tuesday, could suggest Pfizer does not expect

Read the full 464 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers